FREE ACCESS

Sign in with Google to continue in IP News.

Google SSO gives you the quickest path into the IIPLA newsroom, your reading access, and member-level continuity across articles. The full login page is still available if you prefer another option.

By continuing you agree to our terms and privacy policy.

Already have an account? Log in · Create account

Members-only content

IIPLA News
Wednesday, May 13, 2026
LitigationUSAEuropeUK

Biotech Patent Litigation Evolves Amid Rising Biosimilar Competition and Cross-Border Disputes

2025 marks a pivotal year for biotech patent enforcement with landmark cases on aflibercept formulations spanning Europe, the US, and Asia, highlighting shifting litigation dynami…

IIPLA News Desk•anonymous access•0 articles left this week
Biotech Patent Litigation Evolves Amid Rising Biosimilar Competition and Cross-Border Disputes
Sign In To Continue

You have reached the guest article limit.

Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.

Sign in with SSOBecome a paid member
The year 2025 witnessed significant developments in biotech patent litigation, particularly involving biosimilars of aflibercept, a key biologic marketed as Eylea®. Litigation activity intensified across multiple jurisdictions, including England, Germany, the United States, South Korea, and Japan, reflecting a more co…
Share This Article
Ready-to-post copy includes the article link.

Biotech Patent Litigation Evolves Amid Rising Biosimilar Competition and Cross-Border Disputes The year 2025 witnessed significant developments in biotech patent litigation, particularly involving biosimilars of aflibercept, a key biologic marketed as Eylea®. Litigation activity intensified across multiple jurisd... Read the full IIPLA article: https://iipla.org/news/biotech-patent-litigation-evolves-amid-rising-biosimilar-competition-and-cross-border-disputes

LinkedInXFacebookWhatsAppTelegramEmail
Related Coverage

Continue in the newsroom

Back to newsroom
PatentsChina

Strategic IP Risk Management Essential for Chinese Firms Expanding Globally

As Chinese companies pursue growth in international markets, they encounter intricate intellectual property risks including patent infringement litigation, trademark disputes, and trade secret vulnerabilities. The territorial nature of IP rights, diverse legal frameworks, and increasing regulatory scrutiny in mature m…

Wednesday, May 13, 2026
Domain / Digital RightsChina

China Advances Internet IP Protection with Legislative Updates and Judicial Clarifications

China has strengthened its legal framework governing internet intellectual property through the revised Anti-Unfair Competition Law, clarified judicial standards for domain name protection, and intensified enforcement obligations for e-commerce platforms. These developments reflect a comprehensive approach to addressi…

Wednesday, May 13, 2026
PatentsIndia

India's Patent Filings Soar Amid Innovation Challenges and Examination Delays

India has witnessed a remarkable increase in patent filings over the past decade, with domestic innovation driving much of this growth. Government reforms have facilitated accessibility and accelerated processing, contributing to India’s rise in global innovation indices. However, recent data reveals a sharp decline i…

Wednesday, May 13, 2026
PatentsEurope

Managing IP Unveils Shortlists for 2023 EMEA Intellectual Property Awards

Managing IP has announced the shortlists for its 18th annual EMEA Awards, recognising exceptional intellectual property work across multiple jurisdictions and practice areas. The winners will be revealed at a ceremony in London on June 21, with special awards to be announced at the event. The awards programme is widel…

Wednesday, May 13, 2026